Drug-induced lupus erythematosus by amiodarone

Archives of Internal Medicine

Volumn 162, Issue 7, 2002, Pages 834-836

  Sheikhzadeh, Abdalhamid ^a   Schäfer, Ulrich ^a   Schnabel, Armin ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Rheumatology Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; PHENPROCOUMON;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; COUGHING; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG EXPOSURE; DRUG INDUCED DISEASE; DYSPNEA; ENDOCARDITIS; FATIGUE; FEVER; HEART ATRIUM FIBRILLATION; HUMAN; IMAGE ANALYSIS; LUPUS ERYTHEMATOSUS; MALAISE; MALE; MYALGIA; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; THORAX PAIN;

EID: 0037041389     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.7.834     Document Type: Article

References (12)

1. Clinical features of SLE
2. Clinical organ toxicity of antiarrhythmic compounds: Ocular and pulmonary manifestations
3. Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity
4. Acute necrotizing pneumonitis and hyperglycemia after amiodarone therapy: Case report and review of amiodarone-associated pulmonary disease
5. Side effects of long-term amiodarone therapy
6. Amiodarone-associated pulmonary fibrosis: Evidence of an immunologically mediated mechanism
7. Teaching monograph: Tissue reactions to drugs
8. Side effects and complications of amiodarone therapy
9. Amiodarone and its desethyl metabolite: Tissue distribution and morphologic changes during long-term therapy
10. Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats
11. Amiodarone pharmacokinetics
12. Amiodarone induced lupus